Skip to content
Secondary Progressive MS treatment fast-tracked for FDA Approval
avatar
hackwriter posted:
Opexa has changed the name of its drug, Tovaxin, to Tcelna, as it relaunches Phase IIb trials in 2012 in SPMS patients. See details in the link below:

http://www.opexatherapeutics.com/?page=tovaxin&section=tovaxin

Currently there is only one FDA-approved treatment for SPMS. Novantrone, originally a cancer chemotherapy, is an infusion therapy performed once every three months for up to 24 months for the treatment of Secondary-Progressive MS.
Was this Helpful?
2 of 3 found this helpful
Reply


Featuring Experts

Neil S. Lava, MD, is the director of the multiple sclerosis clinic at Emory University in Atlanta. He has been treating multiple sclerosis patients si...More

Helpful Tips

the walking drug, ampyra
was diagnosedwith MS in 2000. my walking has been getting harder to do but i was still able to work. i recently had an exacerbation of my ... More
Was this Helpful?
51 of 62 found this helpful

Related News

There was an error with this newsfeed

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.